Citation Impact
Citing Papers
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes
2004 StandoutNobel
Flavivirus Replication Complex Assembly Revealed by DNAJC14 Functional Mapping
2012 StandoutNobel
Human Adaptation of Ebola Virus during the West African Outbreak
2016
Visualization of plasmid delivery to keratinocytes in mouse and human epidermis
2011
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
2022 StandoutNobel
Serological Memory and Long-term Protection to Novel H1N1 Influenza Virus After Skin Vaccination
2011
The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein
2004
Stability of influenza vaccine coated onto microneedles
2012
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage
2010
Microneedle Vaccination with Stabilized Recombinant Influenza Virus Hemagglutinin Induces Improved Protective Immunity
2011
Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model
2010
Dissolvable Microneedle Patches for the Delivery of Cell-Culture-Derived Influenza Vaccine Antigens
2011
The Role of Lipid Microdomains in Virus Biology
2004
Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles
2011
Microneedles in Clinical Practice–An Exploratory Study Into the Opinions of Healthcare Professionals and the Public
2010
Two-photon polymerization of microneedles for transdermal drug delivery
2010
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV
2005
Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer
2009
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
The landscape of mRNA nanomedicine
2022
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles
2010
Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins
2007
Programming the magnitude and persistence of antibody responses with innate immunity
2011 Nature
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
2010 StandoutNobel
Separable arrowhead microneedles
2010
Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin
2009
Virus-like particles in vaccine development
2010
Delivery materials for siRNA therapeutics
2013 Standout
Palmitoylation and Intracellular Domain Interactions Both Contribute to Raft Targeting of Linker for Activation of T Cells
2005
Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin
2009
Viruses as Building Blocks for Materials and Devices
2007
Determination of parameters for successful spray coating of silicon microneedle arrays
2011
Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles
2010
Structure of Dengue Virus
2002 Standout
Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme
2008
Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic
2009
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Membrane vesicles as conveyors of immune responses
2009 Standout
Bacillus Calmette-Guérin vaccination using a microneedle patch
2011
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
2009
An electrically active microneedle array for electroporation
2009
Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles
2010
Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine
2010
Advances in Virus-Like Particle Vaccines for Filoviruses
2011
Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis
2008
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
2012
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Fabrication of Dissolving Polymer Microneedles for Controlled Drug Encapsulation and Delivery: Bubble and Pedestal Microneedle Designs
2010
Improved influenza vaccination in the skin using vaccine coated microneedles
2009
Ebola Virus‐Like Particle–Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge
2007
Membrane lipids: where they are and how they behave
2008 Standout
Role of Lipid Rafts in Virus Replication
2005
Microneedle arrays as medical devices for enhanced transdermal drug delivery
2011
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin
2010
Delivery of salmon calcitonin using a microneedle patch
2011
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
2007
Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
2008
Microneedles for drug and vaccine delivery
2012 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Enhanced Memory Responses to Seasonal H1N1 Influenza Vaccination of the Skin with the Use of Vaccine‐Coated Microneedles
2009
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge
2010
Knocking down barriers: advances in siRNA delivery
2009 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
2020 Standout
Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents
2007
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
2008
Dissolving polymer microneedle patches for influenza vaccination
2010
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
SARS-CoV-2 vaccines in development
2020 StandoutNature
The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts
2009
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Pharmacokinetic and Pharmacodynamic Evaluation of Insulin Dissolving Microneedles in Dogs
2010
Reassortment and Mutation of the Avian Influenza Virus Polymerase PA Subunit Overcome Species Barriers
2011 StandoutNobel
Self-Assembly of “S-Bilayers”, a Step Toward Expanding the Dimensionality of S-Layer Assemblies
2013 StandoutNobel
Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2
2003
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
2007
Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses
2007
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of Serum Neutralizing Antibodies against Highly Pathogenic Avian Influenza Virus
2007
Regulation of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion by a Membrane-Interactive Domain in the gp41 Cytoplasmic Tail
2005
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified Cytokines
2007
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites
2015
Hepatitis C Virus Core Protein Associates with Detergent-Resistant Membranes Distinct from Classical Plasma Membrane Rafts
2004 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Semliki Forest virus-derived virus-like particles: characterization of their production and transduction pathways
2005
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus
2007
A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
2020
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
2015
Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles
2007
Lipid Rafts, Detergent-Resistant Membranes, and Raft Targeting Signals
2006
Site‐Selectively Coated, Densely‐Packed Microprojection Array Patches for Targeted Delivery of Vaccines to Skin
2010
Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice
2010
High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses
2010
Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions
2012
Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization
2010
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models
2019
Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses
2008
Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses
2008
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA
2012
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
2008
Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression
2001
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Virulence and Genetic Compatibility of Polymerase Reassortant Viruses Derived from the Pandemic (H1N1) 2009 Influenza Virus and Circulating Influenza A Viruses
2011
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Works of Chinglai Yang being referenced
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
2009
Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs
2012
Palmitoylation of the Murine Leukemia Virus Envelope Glycoprotein Transmembrane Subunits
1996
Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies
2004
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
2008
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies
2006
Newcastle Disease Virus-Vectored Rabies Vaccine Is Safe, Highly Immunogenic, and Provides Long-Lasting Protection in Dogs and Cats
2011
A Naturally Occurring Deletion in Its NS Gene Contributes to the Attenuation of an H5N1 Swine Influenza Virus in Chickens
2007
Chimeric Influenza Virus Hemagglutinin Proteins Containing Large Domains of the Bacillus anthracis Protective Antigen: Protein Characterization, Incorporation into Infectious Influenza Viruses, and Antigenicity
2005
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
2006
Coreceptor-Dependent Inhibition of the Cell Fusion Activity of Simian Immunodeficiency Virus Env Proteins
2000
Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain
2004
An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination
2021
An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
2016
Palmitoylation of the Murine Leukemia Virus Envelope Protein Is Critical for Lipid Raft Association and Surface Expression
2002
Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses
2006
Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses
2010
Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate Virus Production and Infectivity
2014